OpenAlex
PricingAboutJobs
Log inGet started
Work

Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation

HTML

Year: 2009
Type: article
Source: Annals of Internal Medicine
DOI: 10.7326/0003-4819-150-2-200901200-00005
Authors: Mark H. Eckman, Jonathan Rosand, Steven M. Greenberg, Brian F. Gage
Institutions: Washington University in St. Louis, Massachusetts General Hospital, University of Cincinnati
Language: English

Topic: Pharmacogenetics and Drug Metabolism
Subfield: Pharmacology
Field: Pharmacology, Toxicology and Pharmaceutics
Domain: Life Sciences
Keywords: warfarin, pharmacogenetics, genotype-guided dosing, non-valvular atrial fibrillation, cost-effectiveness, CYP2C9, VKORC1, major bleeding, genetic testing, quality-adjusted life years, anticoagulation, CYP2C9*2, CYP2C9*3, FDA labeling
SDG: Good health and well-being

Open Access status: closed

Funders: National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke
Awards: A Patient-Specific Decision Support Tool for Bariatric Surgery, G4638051875, G4723344802, Genetic Determinants of Hematoma Volume, G6148728413
OpenAlex ID: W2067315990
FWCI: 31.99
Cites: 67
Cited by: 300
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms